Increased use of the Redsense device at top US dialysis providers
The Redsense technology is becoming available to more patients in the US, as several leading dialysis providers have decided to incorporate the device in their clinical practice. The Redsense device is now introduced at the facilities of the Rogosin Institute, long recognized as one of the premier centers in the US for kidney disease diagnosis and management. The institute, which ranks among the top 10 dialysis providers in the US, operates nine dialysis centers in the NYC area with about 1,500 patients on hemodialysis. In addition to this, 10 patients undergoing treatment at the